Mayo clinic launches lung disease biobank to unlock future treatments

NCT ID NCT03478826

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is creating a repository of blood samples from 635 people with interstitial lung diseases (ILD), pneumonia, and healthy volunteers. Researchers hope these samples will help identify biomarkers to improve diagnosis and treatment. No experimental treatments are given; participants simply donate blood for future studies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this repository could help researchers discover biomarkers that guide treatment for interstitial lung diseases.

What could go wrong

This is an observational study that does not test any treatment. It only collects samples for future research, so there is no direct benefit to participants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PNEUMONIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

interstitial lung disease pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mayo Clinic

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••